Glycemic control in the burn intensive care unit: Focus on the role of anemia in glucose measurement

Journal of Diabetes Science and Technology

Volumn 3, Issue 6, 2009, Pages 1319-1329

  Mann, Elizabeth A ^a   Mora, Alejandra G ^a   Pidcoke, Heather F ^a   Wolf, Steven E ^a   Wade, Charles E ^a  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

Artificial pancreas; Burn; Computer decision support; Continuous glucose monitor; Diurnal variation; Glucometer; Glucose variability; Hematocrit effect; Hypoglycemia; Intensive insulin therapy

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ANEMIA; ARTIFICIAL PANCREAS; BLOOD; BLOOD GLUCOSE MONITORING; BURN; CIRCADIAN RHYTHM; DRUG EFFECT; EQUIPMENT; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HOSPITAL INFORMATION SYSTEM; HUMAN; HYPERGLYCEMIA; INSTRUMENTATION; INTENSIVE CARE; INTENSIVE CARE UNIT; METABOLISM; PREDICTION AND FORECASTING; REPRODUCIBILITY; REVIEW; TREATMENT OUTCOME;

ANEMIA; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BURNS; CIRCADIAN RHYTHM; DIAGNOSTIC EQUIPMENT; HEMATOCRIT; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE; INTENSIVE CARE UNITS; PANCREAS, ARTIFICIAL; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 77957299870     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680900300612     Document Type: Conference Paper

References (86)

1. Gale SC, Sicoutris C, Reilly PM, Schwab CW, Gracias VH. Poor glycemic control is associated with increased mortality in critically ill trauma patients. Am Surg. 2007;73(5):454-60. (Pubitemid 351412051)
2. Gandhi GY, Murad MH, Flynn DN, Erwin PJ, Cavalcante AB, Bay Nielsen H, Capes SE, Thorlund K, Montori VM, Devereaux PJ. Effect of perioperative insulin infusion on surgical morbidity and mortality: systematic review and meta-analysis of randomized trials. Mayo Clin Proc. 2008;83(4):418-30. (Pubitemid 351536467)
3. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79(8):992-1000. (Pubitemid 39007018)
4. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2004;164(19):2005-11. (Pubitemid 39390557)
5. Reed CC, Stewart RM, Sherman M, Myers JG, Corneille MG, Larson N, Gerhardt S, Beadle R, Gamboa C, Dent D, Cohn SM, Pruitt BA Jr. Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. J Am Coll Surg. 2007;204(5):1048-55.
6. Scalea TM, Bochicchio GV, Bichicchio KM, Johnson SB, Joshi M, Pyle A. Tight glycemic control in critically injured trauma patients. Ann Surg. 2007;246(4):605-12.
7. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-61. (Pubitemid 43200296)
8. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-67.
9. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-97.
10. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933-44.
11. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, Syed SJ, Giridhar HR, Rishu AH, Al-Daker MO, Kahoul SH, Britts RJ, Sakkijha MH. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36(12):3190-7.
12. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-39.
13. De La Rosa Gdel C, Donado JH, Restrepo AH, Quintero AM, González LG, Saldarriaga NE, Bedoya M, Toro JM, Velásquez JB, Valencia JC, Arango CM, Aleman PH, Vasquez EM, Chavarriaga JC, Yepes A, Pulido W, Cadavid CA, Grupo de Investigacion en Cuidado intensivo: GICI-HPTU. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intesive care unit: a randomised clinical trial. Crit Care. 2008;12(5):R120.
14. Egi M, Bellomo R, Stachowski E, French CJ, Hart G, Stow P, Li W, Bates S. Intensive insulin therapy in postoperative intensive care unit patients: a decision analysis. Am J Respir Crit Care Med. 2006;173(4):407-13. (Pubitemid 43228328)
15. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE, American Association of Clinical Endocrinologists, American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119-31.
16. Surviving Sepsis Campaign. Statement on glucose control in severe sepsis. http://www.survivingsepsis.org/About-the-Campaign/Documents/SSC. Accessed October 27, 2009.
17. Atiyeh BS, Gunn SW, Dibo SA. Metabolic implications of severe burn injuries and their management: a systematic review of the literature. World J Surg. 2008;32(8):1857-69.
18. Jeschke MG, Chinkes DL, Finnerty CC, Kulp G, Suman OE, Norbury WB, Branski LK, Gauglitz GG, Mlcak RP, Herndon DN. Pathophysiologic response to severe burn injury. Ann Surg. 2008;248(3):387-401.
19. Wolfe RR, Durkot MJ, Allsop JR, Burke JF. Glucose metabolism in severely burned patients. Metabolism. 1979;28(10):1031-9. (Pubitemid 10201201)
20. Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ 3rd, Jeschke MG. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab. 2009;94(5):1656-64.
21. Hart DW, Wolf SE, Mlcak R, Chinkes DL, Ramzy PI, Obeng MK, Ferrando AA, Wolfe RR, Herndon DN. Persistence of muscle catabolism after severe burn. Surgery. 2000;128(2):312-9. (Pubitemid 30622500)
22. Wanek S, Wolf SE. Metabolic response to injury and role of anabolic hormones. Curr Opin Clin Nutr Metab Care. 2007;10(3):272-7. (Pubitemid 46596701)
23. Mann EA, Pidcoke HF, Salinas J, Holcomb JB, Wolf SE, Wade CE. The impact of intensive insulin protocols and restrictive blood transfusion strategies on glucose measurement in American Burn Association (ABA) verified burn centers. J Burn Care Res. 2008;29(5):718-23.
24. Mowlavi A, Andrews K, Milner S, Herndon DN, Heggers JP. The effects of hyperglycemia on skin graft survival in the burn patient. Ann Plast Surg. 2000;45(6):629-32.
25. Pham TN, Warren AJ, Phan HH, Molitor F, Greenhalgh DG, Palmieri TL. Impact of tight glycemic control in severely burned children. J Trauma. 2005;59(5):1148-54. (Pubitemid 43060971)
26. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma. 2001;51(3):540-4. (Pubitemid 33009642)
27. Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet. 2004;363(9424):1895-902. (Pubitemid 38748648)
28. Gauglitz GG, Herndon DN, Jeschke MG. Insulin resistance postburn: underlying mechanisms and current therapeutic strategies. J Burn Care Res. 2008;29(5):683-94.
29. DeSanti L. Pathophysiology and current management of burn injury. Adv Skin Wound Care. 2005;18(6):323-32.
30. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821-7.
31. Collier B, Diaz J Jr, Forbes R, Morris J Jr, May A, Guy J, Ozdas A, Dupont W, Miller R, Jensen G. The impact of a normoglycemic management protocol on clinical outcomes in the trauma intensive care unit. JPEN J Parenter Enteral Nutr. 2005;29(5):353-9.
32. Wahl WL, Taddonio M, Maggio PM, Arbabi S, Hemmila MR. Mean glucose values predict trauma patient mortality. J Trauma. 2008;65(1):42-8.
33. Hemmila MR, Taddonio MA, Arbabi S, Maggio PM, Wahl WL. Intensive insulin therapy is associated with reduced infectious complications in burn patients. Surgery. 2008;144(4):629-37.
34. Jeschke MG, Boehning DF, Finnerty CC, Herndon DN. Effect of insulin on the inflammatory and acute phase response after burn injury. Crit Care Med. 2007;35(9 Suppl):S519-23. (Pubitemid 47312188)
35. Thomas SJ, Morimoto K, Herndon DN, Ferrando AA, Wolfe RR, Klein GL, Wolf SE. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery. 2002;132(2):341-7. (Pubitemid 35024782)
36. Zhang XJ, Chinkes DL, Wolf SE, Wolfe RR. Insulin but not growth hormone stimulates protein anabolism in skin wound and muscle. Am J Physiol. 1999;276(4 Pt 1):E712-20. (Pubitemid 29211344)
37. Pierre EJ, Barrow RE, Hawkins HK, Nguyen TT, Sakurai Y, Desai M, Wolfe RR, Herndon DN. Effects of insulin on wound healing. J Trauma. 1998;44(2):342-5. (Pubitemid 28124175)
38. Ferrando AA, Chinkes DL, Wolf SE, Matin S, Herndon DN, Wolfe RR. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg. 1999;229(1):11-8. (Pubitemid 30190375)
39. Gore DC, Wolf SE, Sanford AP, Herndon DN, Wolfe RR. Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. Am J Physiol Endocrinol Metab. 2004;286(4):E529-34. (Pubitemid 38374949)
40. Pidcoke HF, Wade CE, Wanek S, Wang JJ, Concannon M, Loo F, Wolf SE. Decreased mortality in adult burns with improved glucose control [Abstract]. 13th Congress International Society for Burn Injuries; Sept 25-29, 2006; Fortaleza, Brazil 2006.
41. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105(2):244-52. (Pubitemid 44148168)
42. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36(11):3008-13.
43. Ali NA, O'Brien JM Jr, Dungan K, Phillips G, Marsh CB, Lemeshow S, Connors AF Jr, Preiser JC. Glucose variability and mortality in patients with sepsis. Crit Care Med. 2008;36(8):2316-21.
44. Pidcoke HF, Rohleder L, Wanek SM, Wang J, Holcomb JB, Wolf SE, Wade CE. Glucose variability associated with mortality in burns [Abstract]. J Trauma 2007;62:272.
45. Hobson KG, Havel PJ, McMurtry AL, Lawless MB, Palmieri TL, Greenhalgh DD. Circulating leptin and cortisol after burn injury: loss of diurnal pattern. J Burn Care Rehab. 2004;25(6):491-9. (Pubitemid 39491903)
46. Egi M, Bellomo R, Stachowski E, French CJ, Hart G, Stow P. Circadian rhythm of blood glucose values in critically ill patients. Crit Care Med. 2007;35(2):416-21. (Pubitemid 46148530)
47. Pidcoke HF, Salinas J, Wanek SM, Concannon M, Loo F, Wirfel KL, Holcomb JB, Wolf SE, Wade CE. Patterns of exogenous insulin requirement reflect insulin sensitivity changes in trauma. Am J Surg. 2007;194(6):798-803. (Pubitemid 350086540)
48. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6):409-17.
49. Kwan P, Gomez M, Cartotto R. Safe and successful restriction of transfusion of burn patients. J Burn Care Res. 2006;27(6):826-34. (Pubitemid 44715322)
50. LifeScanHealthcare. SureStepPro Professional Blood Glucose Management System: test strips for glucose testing in whole blood. Milpitas: LifeScan, Johnson & Johnson; 2003.
51. U.S. Food and Drug Administration. Review criteria assessment of portable blood glucose monitoring in vitro diagnostic devices using glucose oxidase, dehydrogenase or hexokinase methodology. U.S. Department of Health and Human Services, 1996.
52. American Diabetes Association. Position statement: self-monitoring of blood glucose. Diabetes Care. 1996;19:62S-6S.
53. Karon BS, Griesmann L, Scott R, Bryant SC, Dubois JA, Shirey TL, Presti S, Santrach PJ. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters. Diabetes Technol Ther. 2008;10(2):111-20. (Pubitemid 351230287)
54. Louie RF, Tang Z, Sutton DV, Lee JH, Kost GJ. Point-of-care glucose testing: effects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch Pathol Lab Med. 2000;124(2):257-66. (Pubitemid 30090612)
55. Tang Z, Lee JH, Louie RF, Kost GJ. Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Arch Pathol Lab Med. 2000;124(8):1135-40. (Pubitemid 30650312)
56. Pidcoke HF, Wade CE, Mann EA, et al. Anemia causes hypoglycemia in intensive care unit patients due to error in single-channel glucometers: methods of reducing patient risk. Crit Care Med. 2009 Sept 28, epub ahead of print. DOI: 10.1097/CCM.0b013e3181bc826f.
57. Cook A, Laughlin D, Moore M, North D, Wilkins K, Wong G, Wallace-Scroggs A, Halvorsen L. Differences in glucose values obtained from point-of-care glucose meters and laboratory analysis in critically ill patients. Am J Crit Care. 2009;18(1):65-72.
58. Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hebert PC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33(12):2778-85. (Pubitemid 41816412)
59. Lee JH, Tang ZP, Louie RF, Kost GJ. The effect of hematocrit on six glucose meter systems for point-of-care testing [Abstract]. AACC/ASCLS 1999 Annual Meeting; July 25-29, 1999; New Orleans, LA: Medical Pathology and Clinical Chemistry, University of California Davis Health System, Sacramento, CA; 1999.
60. Boyd R, Leigh B, Stuart P. Capillary versus venous bedside blood glucose estimations. Emerg Med J. 2005;22(3):177-9. (Pubitemid 40361366)
61. Critchell CD, Savarese V, Callahan A, Aboud C, Jabbour S, Marik P. Accuracy of bedside capillary blood glucose measurements in critically ill patients. Intensive Care Med. 2007;33(12):2079-84. (Pubitemid 350164561)
62. Desachy A, Vuagnat AC, Ghazali AD, Baudin OT, Longuet OH, Calvat SN, Gissot V. Accuracy of bedside glucometry in critically ill patients: influence of clinical charateristics and perfusion index. Mayo Clin Proc. 2008;83(4):400-5. (Pubitemid 351536465)
63. Slater-MacLean L, Cembrowski G, Chin D, Shalapay C, Binette T, Hegadoren K, Newburn-Cook C. Accuracy of glycemic measurements in the critically ill. Diabetes Technol Ther. 2008;10(3):169-77. (Pubitemid 351677597)
64. Mann EA, Salinas J, Pidcoke HF, Wolf SE, Holcomb JB, Wade CE. Error rates resulting from anemia can be corrected in multiple commonly used point-of-care glucometers. J Trauma. 2008;64(1):15-21.
65. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ. The CRIT Study: anemia and blood transfusion in the critically ill - current clinical practice in the United States. Crit Care Med. 2004;32(1):39-52. (Pubitemid 38125561)
66. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D, ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288(12):1499-507.
67. Jeschke MG, Chinkes DL, Finnerty CC, Przkora R, Pereira CT, Herndon DN. Blood transfusions are associated with increased risk for development of sepsis in severely burned pediatric patients. Crit Care Med. 2007;35(2):579-83. (Pubitemid 46148551)
68. Palmieri TL, Caruso DM, Foster KN, Cairns BA, Peck MD, Gamelli RL, Mozingo DW, Kagan RJ, Wahl W, Kemalyan NA, Fish JS, Gomez M, Sheridan RL, Faucher LD, Latenser BA, Gibran NS, Klein RL, Solem LD, Saffle JR, Morris SE, Jeng JC, Voigt D, Howard PA, Molitor F, Greenhalgh DG, American Burn Association Burn Multicenter Trials Group. Effect of blood transfusion on outcome after major burn injury: a multicenter study. Crit Care Med. 2006;34(6):1602-7. (Pubitemid 43810037)
69. Palmieri TL, Lee T, O'Mara MS, Greenhalgh DG. Effects of restrictive blood transfusion policy on outcomes in children with burn injury. J Burn Care Res. 2007;28(1):65-70. (Pubitemid 46087858)
70. Rao LV, Jakubiak F, Sidwell JS, Winkelman JW, Snyder ML. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clin Chim Acta. 2005;356(1-2):178-83. (Pubitemid 40779900)
71. Mann E, Pidcoke H, Salinas J, Holcomb J, Wade C, Wolf S. Hematocrit effect outweighs other sources of glucometer error in critical care. Crit Care Med. 2007;35(12):A140.
72. Thomas LE, Kane MP, Bakst G, Busch RS, Hamilton RA, Abelseth JM. A glucose meter accuracy and precision comparison: the Freestyle Flash versus the Accu-Chek Advantage, Accu- Chek Compact Plus, Ascensia Contour, and the BD Logic. Diabet Technol Ther. 2008;10(2):102-10. (Pubitemid 351232863)
73. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care. 2007;30(2):403-9. (Pubitemid 46198356)
74. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabet Med. 2006;23(1):1-12.
75. Steil GM, Clark B, Kanderian S, Rebrin K. Modeling insulin action for development of a closed-loop artificial pancreas. Diabetes Technol Ther. 2005;7(1):94-108. (Pubitemid 40354579)
76. Bequette BW. A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol Ther. 2005;7(1):28-47. (Pubitemid 40354574)
77. Goldberg PA, Siegel MD, Russell RR, Sherwin RS, Halickman JI, Cooper DA, Dziura JD, Inzucchi SE. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther. 2004;6(3):339-47. (Pubitemid 38821619)
78. Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care. 2006;15(4):370-7. (Pubitemid 44859176)
79. Davidson PC, Steed RD, Bode BW. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care. 2005;28(10):2418-23. (Pubitemid 41384287)
80. Juneja R, Roudebush C, Kumar N, Macy A, Golas A, Wall D, Wolverton C, Nelson D, Carroll J, Flanders SJ. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther. 2007;9(3):232-40. (Pubitemid 46959788)
81. Saager L, Collins GL, Burnside B, Tymkew H, Zhang L, Jacobsohn E, Avidan M. A randomized study in diabetic patients undergoing cardiac surgery comparing computer-guided glucose management with a standard sliding scale protocol. J Cardiothorac Vasc Anesth. 2008;22(3):377-82. (Pubitemid 351713544)
82. Vogelzang M, Loef BG, Regtien JG, van der Horst IC, van Assen H, Zijlstra F, Nijsten MW. Computer-assisted glucose control in critically ill patients. Intensive Care Med. 2008;34(8):1421-7.
83. Morris AH, Orme J Jr, Truwit JD, Steingrub J, Grissom C, Lee KH, Li GL, Thompson BT, Brower R, Tidswell M, Bernard GR, Sorenson D, Sward K, Zheng H, Schoenfeld D, Warner H. A replicable method for blood glucose control in critically ill patients. Crit Care Med. 2008;36(6):1787-95.
84. Dortch MJ, Mowery NT, Ozdas A, Dossett L, Cao H, Collier B, Holder G, Miller RA, May AK. A computerized insulin infusion titration protocol improves glucose control with less hypoglycemia compared to a manual titration protocol in a trauma intensive care unit. JPEN J Parenter Enteral Nutr. 2008;32(1):18-27.
85. Kaukonen KM, Rantala M, Pettilä V, Hynninen M. Severe hypoglycemia during intensive insulin therapy. Acta Anaesthesiol Scand. 2009;53(1):61-5.
86. McMullin J, Brozek J, McDonald E, Clarke F, Jaeschke R, Heels-Ansdell D, Leppert R, Foss A, Cook D. Lowering of glucose in critical care: a randomized pilot trial. J Crit Care. 2007;22(2):112-9.